237 related articles for article (PubMed ID: 21876768)
1. Differential bone marrow homing capacity of VLA-4 and CD38 high expressing chronic lymphocytic leukemia cells.
Brachtl G; Sahakyan K; Denk U; Girbl T; Alinger B; Hofbauer SW; Neureiter D; Hofbauer JP; Egle A; Greil R; Hartmann TN
PLoS One; 2011; 6(8):e23758. PubMed ID: 21876768
[TBL] [Abstract][Full Text] [Related]
2. The pathogenic relevance of the prognostic markers CD38 and CD49d in chronic lymphocytic leukemia.
Brachtl G; Piñón Hofbauer J; Greil R; Hartmann TN
Ann Hematol; 2014 Mar; 93(3):361-74. PubMed ID: 24288111
[TBL] [Abstract][Full Text] [Related]
3. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow.
Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R
Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181
[TBL] [Abstract][Full Text] [Related]
4. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Gooden CE; Jones P; Bates R; Shallenberger WM; Surti U; Swerdlow SH; Roth CG
Cytometry B Clin Cytom; 2018 Jan; 94(1):129-135. PubMed ID: 27221715
[TBL] [Abstract][Full Text] [Related]
5. CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells.
Damle RN; Temburni S; Calissano C; Yancopoulos S; Banapour T; Sison C; Allen SL; Rai KR; Chiorazzi N
Blood; 2007 Nov; 110(9):3352-9. PubMed ID: 17684154
[TBL] [Abstract][Full Text] [Related]
6. TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner.
Binsky I; Lantner F; Grabovsky V; Harpaz N; Shvidel L; Berrebi A; Goldenberg DM; Leng L; Bucala R; Alon R; Haran M; Shachar I
J Immunol; 2010 May; 184(9):4761-9. PubMed ID: 20357260
[TBL] [Abstract][Full Text] [Related]
7. In vivo intraclonal and interclonal kinetic heterogeneity in B-cell chronic lymphocytic leukemia.
Calissano C; Damle RN; Hayes G; Murphy EJ; Hellerstein MK; Moreno C; Sison C; Kaufman MS; Kolitz JE; Allen SL; Rai KR; Chiorazzi N
Blood; 2009 Nov; 114(23):4832-42. PubMed ID: 19789386
[TBL] [Abstract][Full Text] [Related]
8. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.
Martínez-Moreno M; Leiva M; Aguilera-Montilla N; Sevilla-Movilla S; Isern de Val S; Arellano-Sánchez N; Gutiérrez NC; Maldonado R; Martínez-López J; Buño I; García-Marco JA; Sánchez-Mateos P; Hidalgo A; García-Pardo A; Teixidó J
Leukemia; 2016 Apr; 30(4):861-72. PubMed ID: 26658839
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of new biological markers in chronic lymphocytic leukaemia].
Leković D; Mihaljević B; Kraguljac-Kurtović N; Perunčić-Jovanović M; Bogdanović A; Čolović M; Gotić M
Srp Arh Celok Lek; 2011; 139(11-12):753-8. PubMed ID: 22338471
[TBL] [Abstract][Full Text] [Related]
10. Expression of adhesion molecules in B-cell chronic lymphocytic leukaemia: an analysis in lymphoid compartments--peripheral blood, bone marrow and lymph node.
Nadkarni JJ; Perambakam SM; Rathore VB; Amin KM; Parikh PM; Naresh KN; Advani SH
Cancer Biother Radiopharm; 1998 Aug; 13(4):269-74. PubMed ID: 10850362
[TBL] [Abstract][Full Text] [Related]
11. Adhesion receptors on peripheral blood leukemic B cells. A comparative study on B cell chronic lymphocytic leukemia and related lymphoma/leukemias.
Csanaky G; Matutes E; Vass JA; Morilla R; Catovsky D
Leukemia; 1997 Mar; 11(3):408-15. PubMed ID: 9067581
[TBL] [Abstract][Full Text] [Related]
12. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
[TBL] [Abstract][Full Text] [Related]
13. Methods for Investigating VLA-4 (CD49d/CD29) Expression and Activation in Chronic Lymphocytic Leukemia and Its Clinical Applications.
Zucchetto A; Tissino E; Chigaev A; Hartmann TN; Gattei V
Methods Mol Biol; 2019; 1881():101-112. PubMed ID: 30350200
[TBL] [Abstract][Full Text] [Related]
14. The CD49d/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells.
Zucchetto A; Vaisitti T; Benedetti D; Tissino E; Bertagnolo V; Rossi D; Bomben R; Dal Bo M; Del Principe MI; Gorgone A; Pozzato G; Gaidano G; Del Poeta G; Malavasi F; Deaglio S; Gattei V
Leukemia; 2012 Jun; 26(6):1301-12. PubMed ID: 22289918
[TBL] [Abstract][Full Text] [Related]
15. Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
Aydin S; Grabellus F; Eisele L; Möllmann M; Hanoun M; Ebeling P; Moritz T; Carpinteiro A; Nückel H; Sak A; Göthert JR; Dührsen U; Dürig J
Eur J Haematol; 2011 Jul; 87(1):10-9. PubMed ID: 21692849
[TBL] [Abstract][Full Text] [Related]
16. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
Deaglio S; Vaisitti T; Aydin S; Bergui L; D'Arena G; Bonello L; Omedé P; Scatolini M; Jaksic O; Chiorino G; Efremov D; Malavasi F
Blood; 2007 Dec; 110(12):4012-21. PubMed ID: 17699742
[TBL] [Abstract][Full Text] [Related]
17. The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells.
Fiorcari S; Brown WS; McIntyre BW; Estrov Z; Maffei R; O'Brien S; Sivina M; Hoellenriegel J; Wierda WG; Keating MJ; Ding W; Kay NE; Lannutti BJ; Marasca R; Burger JA
PLoS One; 2013; 8(12):e83830. PubMed ID: 24376763
[TBL] [Abstract][Full Text] [Related]
18. Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia.
Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S
Curr Top Med Chem; 2013; 13(23):2955-64. PubMed ID: 24171772
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow angiogenesis and proliferation in B-cell chronic lymphocytic leukemia.
Wolowiec D; Wozniak Z; Potoczek S; Ganczarski G; Wrobel T; Kuliczkowski K; Frydecka I; Jeleń M
Anal Quant Cytol Histol; 2004 Oct; 26(5):263-70. PubMed ID: 15560532
[TBL] [Abstract][Full Text] [Related]
20. Assessment of expression of selected Bcl-2 family proteins in lymphoid infiltration in patients with B-cell chronic lymphocytic leukaemia treated with nucleoside analogues.
Lemancewicz D; Dziecioł J; Piszcz J; Lebelt A; Mazgajska-Barczyk K; Klim B; Kłoczko J
Folia Histochem Cytobiol; 2008; 46(3):361-6. PubMed ID: 19056541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]